Log In
BCIQ
Print this Print this
 

Normosang

  Manage Alerts
Collapse Summary General Information
Company Recordati S.p.A.
DescriptionHuman hemin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationPorphyria
Indication DetailsTreat hepatic porphyria
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today